These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 14742994

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Anti-interleukin-2 receptor antibody (daclizumab) treatment of corticosteroid-refractory autoimmune thrombocytopenic purpura.
    Fogarty PF, Seggewiss R, McCloskey DJ, Boss CA, Dunbar CE, Rick ME.
    Haematologica; 2006 Feb; 91(2):277-8. PubMed ID: 16461323
    [Abstract] [Full Text] [Related]

  • 44. Dysregulated cytokine responses during cytomegalovirus infection in renal transplant recipients.
    Sadeghi M, Daniel V, Naujokat C, Schnitzler P, Schmidt J, Mehrabi A, Zeier M, Opelz G.
    Transplantation; 2008 Jul 27; 86(2):275-85. PubMed ID: 18645491
    [Abstract] [Full Text] [Related]

  • 45. Induction therapy after cardiac transplantation: a comparison of anti-thymocyte globulin and daclizumab in the prevention of acute rejection.
    Carlsen J, Johansen M, Boesgaard S, Andersen CB, Arendrup H, Aldershvilet J, Mortensen SA.
    J Heart Lung Transplant; 2005 Mar 27; 24(3):296-302. PubMed ID: 15737756
    [Abstract] [Full Text] [Related]

  • 46. Prediction of subclinical renal allograft rejection by vascular endothelial growth factor in serum and urine.
    Peng W, Chen J, Jiang Y, Shou Z, Chen Y, Wang H.
    J Nephrol; 2008 Mar 27; 21(4):535-42. PubMed ID: 18651543
    [Abstract] [Full Text] [Related]

  • 47. WOFIE stimulates regulatory T cells: a 2-year follow-up of renal transplant recipients.
    Dresske B, Haendschke F, Lenz P, Ungefroren H, Jenisch S, Exner B, El Mokhtari NE, Lu T, Zavazava N, Faendrich F.
    Transplantation; 2006 Jun 15; 81(11):1549-57. PubMed ID: 16770244
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis.
    Bielekova B, Catalfamo M, Reichert-Scrivner S, Packer A, Cerna M, Waldmann TA, McFarland H, Henkart PA, Martin R.
    Proc Natl Acad Sci U S A; 2006 Apr 11; 103(15):5941-6. PubMed ID: 16585503
    [Abstract] [Full Text] [Related]

  • 51. Direct inhibition of interleukin-2 receptor alpha-mediated signaling pathway induces G1 arrest and apoptosis in human head-and-neck cancer cells.
    Kuhn DJ, Dou QP.
    J Cell Biochem; 2005 May 15; 95(2):379-90. PubMed ID: 15779002
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. [Interleukin-2 receptor blockers in renal transplantation].
    Basić-Jukić N, Bubić-Filipi L, Danić A, Pasini J, Kes P.
    Acta Med Croatica; 2004 May 15; 58(5):395-9. PubMed ID: 15756806
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Stem cell factor, interleukin-16, and interleukin-2 receptor alpha are predictive biomarkers for delayed and slow graft function.
    Alachkar N, Ugarte R, Huang E, Womer KL, Montgomery R, Kraus E, Rabb H.
    Transplant Proc; 2010 Nov 15; 42(9):3399-405. PubMed ID: 21094786
    [Abstract] [Full Text] [Related]

  • 57. Soluble interleukin-2 receptor (sIL-2R) and tumor necrosis factor plasma levels in renal allograft recipients.
    Noronha IL, Daniel V, Rambausek M, Waldherr R, Opelz G.
    Transplant Proc; 1990 Aug 15; 22(4):1859-60. PubMed ID: 2117814
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody].
    Campana C.
    Ital Heart J Suppl; 2000 Jun 15; 1(6):838-9. PubMed ID: 11204021
    [No Abstract] [Full Text] [Related]

  • 60. An assessment of serum and urine soluble interleukin-2 receptor concentrations during renal transplant rejection.
    Bock GH, Neu L, Long C, Patterson LT, Korb S, Gelpi J, Nelson DL.
    Am J Kidney Dis; 1994 Mar 15; 23(3):421-6. PubMed ID: 8128944
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.